Healthcare providers in the United States lose $262B in revenue annually to insurance claim denials, then spend an additional $26B trying to recover what they are owed – a double penalty that hits practices already operating on narrow margins. The problem compounds based on staffing level: 63% of revenue cycle management (RCM) teams are understaffed, and the role sees 32% annual turnover, leaving billing workflows chronically under-resourced and inconsistent.Amperos Health addresses this structural gap with the first AI-native platform built to manage the full denial and collections workflow end-to-end, from portal follow-ups and calls to corrected claims, medical records, and appeals, eliminating the handoffs and coverage gaps that define legacy point solutions, which typically automate only a single step in the process. The platform integrates directly with providers’ existing billing systems and works every claim systematically regardless of dollar value, while a team of subject matter experts handles the cases that require human judgment on complex or high-difficulty recoveries. The approach has gained measurable traction. Amperos now serves more than 3,000 clinical locations across all 50 states, drives nearly $700M in recovered revenue annually across more than 500,000 claims, and delivers 22% more recovered per claim at up to 50% lower cost to collect than traditional RCM approaches.
AlleyWatch sat down with Amperos Health CEO and Cofounder Michal Miernowski to learn more about the business, its future plans, recent $16M funding round that brings total funding to $20.2M, and much, much more…
Who were your investors and how much did you raise?
Amperos Health announced that it closed a $16M Series A funding round, led by Bessemer Venture Partners, with participation from Uncork Capital and Neo.
Tell us about the product or service that Amperos Health offers.
Amperos is healthcare’s first AI-native denial management and revenue recovery solution designed specifically for healthcare providers to combat denials and streamline claims collections for revenue cycle management (RCM) teams. Providers hand off their denied claims, and Amperos handles everything: follow-ups, appeals, calls, paperwork, the works. The AI that Amperos uses works directly within the provider’s existing billing software, acting like a member of their team rather than a separate platform to manage. The result: providers recover more revenue, at lower cost, without hiring more staff.
What inspired the start of Amperos Health?
I spent years as an investor in healthcare services, working with leaders to improve the financial health of their clinics. There, I saw firsthand how the manual, costly burden of billing prevents clinics from growing, serving more patients, and paying their staff competitively. In 2023, I was inspired to found Amperos alongside my cofounders Alvin (CPO) and Wilson (engineering) to bring complementary product and technical depth.
How is Amperos Health different?
Compared to legacy incumbents, our differentiation is that we provide an agentic workforce that can be easily directed to follow a customer’s SOPs, provide auditing on what was worked when, and achieve better outcomes, including high recovery rates at a lower cost.Our primary differentiator is that Amperos is a true end-to-end platform that can handle a claim from start to finish. Most others in the space only provide a point solution (e.g. AI calling only, appeals only).Amperos uses AI, which means it works on every claim systematically and comprehensively. A $50 denial gets the same follow-through as a $5,000 one – and providers can see every action in real time. The economics are fundamentally different: AI doesn’t get tired, doesn’t quit, and doesn’t need to be retrained. That’s how Amperos can charge 50% less and recover more.
What market does Amperos Health target and how big is it?
Amperos targets the healthcare RCM market. Right now, American providers are denied $262B of revenue each year from insurance, and spend another $26B trying to recover claims. Even then, only 70% of those claims end up getting paid. And yet, 63% of revenue cycle teams are understaffed, and the role sees 32% annual turnover, leaving major gaps in the workforce.
What’s your business model?
Amperos partners with healthcare providers and integrates directly with their billing systems to provide a highly customized solution for customers. Our subscription pricing model is volume-based, to ensure that our customers achieve ROI regardless of the size of their practice.
How has the business changed since we spoke last June after your seed round?
Our goal has remained the same: lead a new standard in healthcare where providers can navigate RCM with ease. Amperos continues to partner with providers to give more complete, faster information about their claims, which is helping both sides resolve disputes more efficiently — which is good for payers too.
What was the funding process like?
We aimed to run a well-structured process and lined up all materials and potential intros leading up to launch date. As a result, within just a day of launching the raise, we had meetings lined up. We ended up signing our term sheet about 10 days after the fundraising process started.
What are the biggest challenges that you faced while raising capital?
While healthcare RCM has attracted a lot of attention from VC, it is a niche sub-industry. The biggest hurdle was really introducing generalist investors to the space and trying to educate them quickly on how healthcare billing works.
What factors about your business led your investors to write the check?
We’ve seen great traction with investors, driven by the real ROI we drive for customers. That, plus the healthcare and AI experience of our team, led investors to underwrite their investment.
We’ve seen great traction with investors, driven by the real ROI we drive for customers. That, plus the healthcare and AI experience of our team, led investors to underwrite their investment.
What are the milestones you plan to achieve in the next six months?
We aim to rapidly evolve the product and by the end of this year, expand into new parts of the RCM workflow beyond denial management — such as preventing denials and addressing root causes automatically.
What advice can you offer companies in New York that do not have a fresh injection of capital in the bank?
I would say the most important thing is to identify the top 2-3 most important things to make your business successful in the next 6-12 months and focus your time and money in those areas.
Where do you see the company going now over the near term?
RCM today is a manual, constantly shifting domain. New payer rules, new procedures, and constant staff turnover. It’s nearly impossible for any billing leader to stay ahead without AI.As Amperos expands from denials into other parts of the revenue cycle, the goal is to become the AI-native infrastructure layer between providers and payers. We don’t want to be just automating the work, but continuously optimizing, to make sure providers can maximize reimbursement. We can make this possible by identifying where denials are occurring and making process changes upstream to prevent them in the first place.
What’s your favorite spring destination in and around the city?
On a rainy spring day – the Met! And on a warm day – Prospect Park!
You are seconds away from signing up for the hottest list in NYC Tech!
Sign up today
